Barriers and Facilitators to Cancer Clinical Trial Participation: Perspectives of Patients in the ICON-3 Practice-Based Research Network, Nigeria
To optimize cancer clinical trial participation in low-resource settings, interventions must be tailored to local contexts, addressing structural and cultural barriers. Enhanced communication, community involvement, and supportive policies can significantly improve trial participation and outcomes.
Authors
- Tara M. Friebel (ORCID: https://orcid.org/0000-0002-3726-9527)
- Ijeoma Uchenna Itanyi (ORCID: https://orcid.org/0000-0002-4958-6319)
- Babayemi O. Olakunde (ORCID: https://orcid.org/0000-0002-0864-6901)
- Anne F. Rositch (ORCID: https://orcid.org/0000-0002-0403-8482)
- Echezona E. Ezeanolue (ORCID: https://orcid.org/0000-0002-6294-9479)
- Richard B.S. Roden (ORCID: https://orcid.org/0000-0002-2506-0195)
- Tonia C. Onyeka (ORCID: https://orcid.org/0000-0001-8138-3100)
- Ngozi Idemili-Aronu (ORCID: https://orcid.org/0000-0001-9719-8153)
- Adaeze Chike-Okoli
- Kimberly Levinson (ORCID: https://orcid.org/0000-0002-6457-9635)
- Tzyy‐Choou Wu
Institutions
- Rutgers, The State University of New Jersey (US)
- University of Nigeria (NG)
- University of North Texas (US)
- Johns Hopkins University (US)
- University of North Texas Health Science Center (US)
- University of Toronto (CA)
- Sunrise Medical (United States) (US)
- Hologic (United States) (US)
- Public Health Ontario (CA)
- Walden University (US)
Publication Details
- Journal
- JCO Global Oncology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1200/go-25-00181
- Citations
- 1
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 1.88